Home Services & Solutions HitS Protein Production DNA-Encoded Library Technology Fragment Based Screening (FBDD) Biophysical & Biochemical Platform Structure-Based Drug Discovery Structure Based Drug Discovery Protein Production X-ray Crystallography CryoEM Biophysical Assays and Screening FBDD - Fragment Screening Biopharmaceutical Assays FTE Chemistry Services Technology Platform PROTAC® Oligo & Conjugation ADC Chemistry AI Quantum Mechanics Flow Chemistry Electrochemistry Photoredox Catalyst Screening Biotransformation Specialty Chemistry Carbohydrate Chemistry Material Science OLED and Polymer Macrocyclic Chemistry Boron Chemistry Deuteration Chemistry Lipids Fluorescent Bio-probe and Labeling Nucleoside/tides Steroids Agricultural Chemistry DPC Fluorine Chemistry Late Stage Functionalization Integrated Discovery DEL High Throughput Screening Virtual Library CADD Biology DMPK Services Toxicology Formulation Development Biology In vitro Biology Enzymes/Biochemical Assays Ion Channel Cellular Assays GPCR, Transporter and NHR Radioactive Assays Cancer Cell Panel & In Vitro Oncology Assays In Vitro Assays for Diabetes and Other Metabolic Diseases High Throughput Screening High Content Platform In vivo Pharmacology & PK/PD Cardiovascular Diseases Metabolic Diseases Fibrosis: Lung, Liver, Kidney Central Nervous System & Pain Respiratory: Asthma & COPD IBS/IBD Animal Models Large Animal Disease Models Infectious Disease Antiviral Services Virology Assays Supporting Human Clinical Trials HBV Platform HBV & HCV Molecular Testing Lab Safety and Early Toxicity In Vitro Safety Profiling for Medchem Support In Vitro Tox Assays for Medchem Support Early Stage Safety Assessment Oncology & Immunology CRISPR/Cas9 Gene Editing In Vitro & In Vivo Library Screening In Vivo CRISPR Animal Models and Services Gene Therapy Tumor Models Cell Line-Derived Xenograft (CDX) Tumor Models Patient-Derived Xenograft (PDX) Tumor Models Syngeneic Tumor Models Human Immune Checkpoint Gene KI Mouse Models hPBMC/HSC Humanized Models Immuno-oncology Translational Oncology Biomarker Discovery Biomarker Clinical Biomarker Autoimmune and Inflammatory Animal Models OncoWuXi Database Chemistry Analysis Separation Center Center of Natural Product Impurity Isolation and Identification Physicochemical Characterization & Others Pharmaceutical Analysis ASMS Screening Academic Therapeutic Areas Cardiovascular Diseases Metabolic Diseases Fibrosis lung, liver, kidney Central Nervous System & Pain Respiratory: Asthma & COPD Infectious Disease Oncology & Immunology Autoimmune and Inflammatory Our Brand Chem-on-Demand HD Biosciences Crelux DELopen DELight About Us About WuXi AppTec RSD RSD Leadership About WuXi AppTec News & Events News Upcoming Events Resource Library Webinar Newsletter Latest Sciences Literature Download Contact
Our Latest Updates on Science and Services OncoWuXi Newsletter Nov 2020 RSDpress Nov 2020 OncoWuXi Newsletter Oct 2020 RSDpress Oct 2020 RSDpress Sep 2020 OncoWuXi Newsletter Sep 2020 OncoWuXi Newsletter Aug 2020 RSDpress Aug 2020 RSDpress July 2020 OncoWuXi Newsletter July 2020 OncoWuXi Newsletter June 2020 OncoWuXi Newsletter May 2020 RSDpress May 2020 OncoWuXi Newsletter April 2020 RSDpress March 2020 OncoWuXi Newsletter March 2020 OncoWuXi Newsletter February 2020 OncoWuXi Newsletter January 2020 OncoWuXi Newsletter December 2019 OncoWuXi Newsletter November 2019 Biology Newsletter November 2019 OncoWuXi Newsletter October 2019 OncoWuXi Newsletter September 2019 OncoWuXi Newsletter August 2019 Biology Newsletter 3D in vitro Assay Platform RSDpress July 2019 RSDpress May 2020 OncoWuXi Newsletter April 2020 RSDpress March 2020 Explore More OncoWuXi Newsletter Nov 2020: FLT3, RET, and RAF-MEK1/2 related tumor models. Oct 2020: Pharmacodynamics service platform. Sep 2020: FACS platform Aug 2020: NanoString platform for research and translational applications July 2020: Genetically engineered Ba/F3 cell lines June 2020: KRAS G12C related in vivo tumor models May 2020: Comprehensive pathology service platform Apr 2020: Drug resistant tumor models March 2020: EGFR related in vivo models Feb 2020: Genetically engineered Ba/F3 cell lines and corresponding in vivo/in vitro validation data Jan 2020: Immune checkpoint knockin humanized mouse tumor models and immune avatar humanized mouse tumor models Dec 2019: Special New Year Edition Nov 2019: Newly developed Luminex multiplex system Oct 2019: Newly developed in vitro angiogenesis assay Sep 2019: STING related assays and updates on KRAS relevant models Aug 2019: Genetically engineered Ba/F3 cell lines and corresponding in vivo/in vitro validation data July 2019: in vivo efficacy platform for bispecific antibodies June 2019: integrated target identification and validation platform March 2019: nanostring platform for research and translational applications February 2019: immune checkpoint humanized knockin mouse tumor models 2019 Special New Year Edition Biology Newsletter Quantitative Histopathology of Fibrosis in an Animal Modal of NASH 3D in vitro Assay Platform Non-alcoholic steatohepatitis (NASH) pharmacology platform Chronic kidney disease (CKD) in vivo pharmacology services Myocardial infarction/heart failure (MI/HF) model in the large animals Nav1.8 - a target analgesic candidates validated by Phase 2 clinical study In vitro early toxicity testing service In vivo anti-hypertension service End-to-end platform supporting HBV drug discovery In vivo pharmacology on IBS/IBD animal models RSDpress RSDpress Nov 2020 RSDpress Oct 2020 RSDpress Sep 2020 RSDpress Aug 2020 RSDpress July 2020 RSDpress May 2020 RSDpress March 2020 RSDpress March 2019 RSDpress December 2018 RSDpress July 2018 RSDpress May 2018 RSDpress February 2018 RSDpress November 2017 RSDpress August 2017 RSDpress March 2017